SNR-18487-94269
5 vaccinations
4 coded responses
43 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 024 / MA
- Registered
- 2021-01-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-04
Registered in v-safe
-
2021-01-04
Dose 1 — Moderna
- 2021-01-04
- 2021-01-06
- 2021-01-07
- 2021-01-08
- 2021-01-09
- 2021-01-13
- 2021-01-18
- 2021-01-25
-
2021-02-01
Dose 2 — Moderna
-
2021-02-01
Survey response — day 0, dose 2MedDRA: Injection site pain — Feeling: GoodFree text: Soreness at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-02
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-03
Survey response — days 1–6 daily, dose 2MedDRA: Injection site pain — Feeling: Good · Headache, Fatigue or tirednessFree text: Soreness at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-04
- 2021-02-05
- 2021-02-06
- 2021-02-07
- 2021-02-08
- 2021-02-15
- 2021-02-22
- 2021-03-01
- 2021-03-08
-
2021-03-15
Survey response — day 42, dose 2MedDRA: Pre-existing disease, Rheumatoid arthritis — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Has a RA relapse (rheumatoid arthritis, which was a pre-existing condition Ive had for many years)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-15
Report sent to call center — day 42, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-03
- 2021-08-02
-
2021-08-17
Dose 3 — Moderna
-
2021-08-23
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-08-24
- 2021-08-31
- 2021-09-09
- 2021-09-14
- 2021-09-21
- 2021-09-28
-
2021-11-16
Survey response — 3 months, dose 3MedDRA: Increased tendency to bruise — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Easily bruisingMedDRA releases: 2024-11 · check-in free text available
-
2021-11-16
Report sent to call center — 3 months, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2021-11-17
- 2022-02-15
-
2022-07-18
Dose 4 — Moderna
- 2022-08-17
-
2022-10-10
Dose 5 — Moderna
- 2022-10-10
- 2022-10-12
- 2022-10-17
- 2022-10-24
- 2022-11-02
- 2022-11-07
- 2022-11-16
- 2022-11-21
- 2023-01-09
- 2023-04-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-04 | Moderna | |
| 2 | 2021-02-01 | Moderna | |
| 3 | 2021-08-17 | Moderna | No |
| 4 | 2022-07-18 | Moderna | No |
| 5 | 2022-10-10 | Moderna | No |
Call center
2 call center cases
2 unsuccessful
Free text
Release 3 — day 0, dose 2
Systemic reaction (other): Soreness at injection site
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Soreness at injection site
Release 5 — day 42, dose 2
Symptoms: Has a RA relapse (rheumatoid arthritis, which was a pre-existing condition Ive had for many years)
Release 10 — 3 months, dose 3
Symptoms: Easily bruising
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Increased tendency to bruise | · | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Rheumatoid arthritis | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release